Stem cell entrepreneurship-trends and advances-II
Why this work is in the frame
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Bibliographic record
Abstract
Stem cell research market in the world has grown exponentially over the last decade and in India the total investment is estimated to be about $540 million in 2010 with an annual growth rate of 15%.1 From just a few Institutes in India two years back, today over 30 institutions are involved in stem cell research with the Indian government investing around $8 million dollars in just the last two years. What is the ultimate goal of Stem Cell research? Today, the ultimate aim of scientists is to be able to build tissues or organs that can replace injured or diseased tissues in the human body. This concept which gives rise to the generation of mature tissues has made adult stem cells the focus of intense research, designed to treat a variety of human diseases. In the clinical scenario, stem cells are expected to be transplanted into the damaged area and then grow to a new, healthy tissue. Considering the immense interest worldwide, it comes as no surprise that the global market for stem cell therapy is around $20 billion in 2010, as per a Frost & Sullivan study. There are almost 180 prominent companies working on stem cell research in the world, majority of which are based in the US, followed by the EU, Israel, Thailand, Canada, and Australia. India and China are poised to play a key role in the scientific, clinical and commercial development of stem cell research. The high patient demand, vibrant pharmaceutical or biotechnological companies, a large intellectual pool of scientific talent and a mature information technology industry have together converted this sub-continent into a big platform for research and clinical translation. The early starters include National Centre For Cell Sciences (Pune), the Indian Institute of Sciences (Bangalore), Post Graduate Institute of Medical Education Reaserch (PGI) and All Indian Institute of Medical Sciences (AIIMS) with central focus on adult stem cells and cord derived stem cells.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.000 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.001 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.001 |
| Insufficient payload (model declined to judge) | 0.000 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it